SENDOX Trademark

Trademark Overview

On Tuesday, November 5, 2002, a trademark application was filed for SENDOX with the United States Patent and Trademark Office. The USPTO has given the SENDOX trademark a serial number of 78181858. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 23, 2008. This trademark is owned by Forest Laboratories, Inc.. The SENDOX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neuropathic pain, diabetic neuropathy, neurological disorders, neurodegenerative disorders, and/or depression; neuroprotective agent.

General Information

Serial Number78181858
Word MarkSENDOX
Filing DateTuesday, November 5, 2002
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 23, 2008
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 27, 2005

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neuropathic pain, diabetic neuropathy, neurological disorders, neurodegenerative disorders, and/or depression; neuroprotective agent.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 18, 2002
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameForest Laboratories, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10022
Party NameForest Laboratories, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10022

Trademark Events

Event DateEvent Description
Wednesday, August 20, 2008ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Wednesday, August 20, 2008ABANDONMENT - NO USE STATEMENT FILED
Wednesday, November 28, 2007EXTENSION 4 GRANTED
Wednesday, November 28, 2007EXTENSION 4 FILED
Wednesday, November 28, 2007TEAS EXTENSION RECEIVED
Wednesday, May 30, 2007EXTENSION 3 GRANTED
Wednesday, May 30, 2007EXTENSION 3 FILED
Wednesday, May 30, 2007TEAS EXTENSION RECEIVED
Thursday, November 30, 2006EXTENSION 2 GRANTED
Thursday, November 30, 2006EXTENSION 2 FILED
Thursday, November 30, 2006TEAS EXTENSION RECEIVED
Monday, June 26, 2006EXTENSION 1 GRANTED
Tuesday, June 6, 2006EXTENSION 1 FILED
Tuesday, June 6, 2006TEAS EXTENSION RECEIVED
Tuesday, December 20, 2005NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 27, 2005PUBLISHED FOR OPPOSITION
Wednesday, September 7, 2005NOTICE OF PUBLICATION
Thursday, June 9, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, June 3, 2005ASSIGNED TO LIE
Thursday, June 2, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 1, 2005AMENDMENT FROM APPLICANT ENTERED
Thursday, May 12, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 12, 2005PAPER RECEIVED
Tuesday, January 4, 2005REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, November 4, 2004ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 4, 2004TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 3, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 18, 2004AMENDMENT FROM APPLICANT ENTERED
Friday, June 18, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 2, 2004REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, June 18, 2004PAPER RECEIVED
Sunday, March 30, 2003LETTER OF SUSPENSION E-MAILED
Thursday, March 27, 2003ASSIGNED TO EXAMINER

Related Keywords

sendox dementia disorders neuropathy neurological neurodegenerative agent neuroprotective depression diabetic neuropathic